Indicators

Markets:

News

Latest News about HZNP

Recent news which mentions HZNP

< Previous 1 2 3 4 5 6 7 8 Next >

Stifel Nicolaus reduced Horizon Therapeutics (HZNP) PT to $138. HZNP is trading at $66.96

August 03, 2022

Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations

August 03, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

August 03, 2022

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session

August 03, 2022

Dow Jumps 350 Points; Crude Oil Drops Over 2%

August 03, 2022

AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday

August 03, 2022

Horizon Therapeutics' Shares Tumble On Q2 Miss, Trimmed FY22 Outlook

August 03, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

August 03, 2022

Horizon Therapeutics: Q2 Earnings Insights

August 03, 2022

Biotech Investors: August's Key PDUFA Catalysts You Must Know

July 31, 2022

Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate

July 08, 2022

Analyst Ratings for Horizon Therapeutics

July 05, 2022

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

July 01, 2022

Analyst Ratings for Horizon Therapeutics

June 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

June 14, 2022

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

May 31, 2022

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More

May 30, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022

May 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

May 23, 2022

4 Analysts Have This to Say About Horizon Therapeutics

May 23, 2022

Horizon Therapeutics Earnings Perspective: Return On Capital Employed

May 19, 2022

Horizon Therapeutics Begins Patient Enrolment in Phase 2 trial of Daxdilimab (HZN-7734) for Alopecia Areata

May 17, 2022

Horizon Therapeutics: Q1 Earnings Insights

May 04, 2022

10 Health Care Stocks With Whale Alerts In Today's Session

May 02, 2022

Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation

May 02, 2022

A Peek Into The Markets: US Stock Futures Higher Following Friday's Sell-Off

May 02, 2022

Will Investors Notice Exciting Sign On Horizon Therapeutics's Chart?

April 28, 2022

Eton Pharmaceuticals Names James Gruber Finance Chief

April 11, 2022

Executives Sell More Than $262M Of 5 Stocks

April 04, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.